Literature DB >> 2425843

Biochemical characterization of human myeloperoxidase using three specific monoclonal antibodies.

Y Morishita, Y Morishima, M Ogura, Y Nagai, R Ohno.   

Abstract

We have developed three monoclonal antibodies (moAbs), MA1, MA3 and MB1, which react with different antigenic determinants of human myeloperoxidase (MPO). In MPO-positive culture cell lines, HL-60 and NKM1, analysis of MPO by pulse-chase experiments followed by immunoprecipitation with these moAbs revealed that MPO was composed of subunits of 59K, 18K and 14.8K dalton polypeptides which are plausibly derived from the 89 K precursor. MA1 and MB1 react with both the precursor and the mature forms of MPO. MA3 reacts with only the mature forms of MPO. Blocking experiments on MPO-related functions revealed that the three moAbs could be divided into two groups. MA1 and MA3 inhibit MPO activities such as tetraguaiacol formation, iodide oxidation and luminol-dependent chemiluminescence, while MB1 shows no such inhibition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425843     DOI: 10.1111/j.1365-2141.1986.tb07520.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study.

Authors:  F Lanza; A Latorraca; P Musto; L Ferrari; S Moretti; G Zabucchi; M Carotenuto; G L Castoldi
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

2.  Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.

Authors:  J Storr; G Dolan; E Coustan-Smith; D Barnett; J T Reilly
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.